Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | TK2 | O00142 | 8/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | TYMP | P19971 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6890252 | 1.00 | TK1 (0.65) | TK1CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL18226895 | 1.00 | TK1 (0.65) | TK1CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL10337895 | 1.00 | TK1 (0.65) | TK1CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL13261412 | 0.98 | TK1 (0.62) | TK1CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL15110503 | 0.88 | TK2 (0.60) | TK1CYP2C9KMT2ATK2MAPT | |
| SCHEMBL4118603 | 0.86 | MAPK1 (0.57) | TK1TK2MAPK1TYMPHPGD | |
| SCHEMBL3465151 | 0.85 | TK2 (0.56) | TK1CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL3467230 | 0.85 | TK2 (0.56) | TK1CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL2497466 | 0.85 | TK2 (0.56) | TK1CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL591657 | 0.83 | TK1 (0.56) | TK1CYP2C9KMT2ATK2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6800370-B2 | SUBSTRATE HAVING PHOTOIONISABLE MOIETIES CAPABLE OF UNDERGOING DIMERIZATION ATTACHED TO A PORTION OF THE SURFACE; IRRADIATION WITH LIGHT OF AN APPROPRIATE WAVELENGTH RESULTS IN DIMERIZATION, THEREBY ALTERING SURFCE WETTABILITY | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2004-10-05 | — | — | US | disclosed |
| US-20020084179-A1 | Substrate having photoionisable moieties capable of undergoing dimerization attached to a portion of the surface; irradiation with light of an appropriate wavelength results in dimerization, thereby altering surfce wettability | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2002-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020084179-A1 | Substrate having photoionisable moieties capable of undergoing dimerization attached to a portion of the surface; irradiation with light of an appropriate wavelength results in dimerization, thereby altering surfce wettability | SPR, SURF4, CLTA | TK1 2316/4885CYP1A2 901/4885CYP2C19 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.